Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,781 to 1,800 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| ATXN3 ataxin 3 | 4287 HGNC:7106 | 1 | 42 | 0 | 0 | 1,882 | 3,790 |
| TNNT1 troponin T1, slow skeletal type | 7138 HGNC:11948 | 1 | 15 | 0 | 0 | 1,327 | 3,788 |
| FAAH fatty acid amide hydrolase | 2166 HGNC:3553 | 1 | 34 | 3 | 299 | 2,032 | 3,784 |
| ORAI1 ORAI calcium release-activated calcium modulator 1 | 84876 HGNC:25896 | 1 | 31 | 0 | 0 | 1,777 | 3,783 |
| SLC4A3 solute carrier family 4 member 3 | 6508 HGNC:11029 | 1 | 16 | 0 | 0 | 674 | 3,779 |
| ARC activity regulated cytoskeleton associated protein | 23237 HGNC:648 | 1 | 29 | 0 | 0 | 3,145 | 3,775 |
| MCM2 minichromosome maintenance complex component 2 | 4171 HGNC:6944 | 1 | 62 | 0 | 0 | 1,980 | 3,775 |
| ERVK-13 endogenous retrovirus group K member 13 | 100861467 HGNC:39008 | 0 | 0 | 0 | 0 | 1,306 | 3,774 |
| TGFBI transforming growth factor beta induced | 7045 HGNC:11771 | 1 | 156 | 0 | 0 | 2,003 | 3,774 |
| MIR106A microRNA 106a | 406899 HGNC:31494 | 0 | 0 | 0 | 0 | 1,242 | 3,773 |
| IVL involucrin | 3713 HGNC:6187 | 1 | 28 | 0 | 0 | 1,524 | 3,772 |
| ATP7B ATPase copper transporting beta | 540 HGNC:870 | 1 | 77 | 0 | 0 | 1,162 | 3,770 |
| AGXT alanine--glyoxylate aminotransferase | 189 HGNC:341 | 1 | 48 | 0 | 0 | 1,683 | 3,768 |
| YTHDF2 YTH N6-methyladenosine RNA binding protein F2 | 51441 HGNC:31675 | 1 | 23 | 0 | 0 | 996 | 3,768 |
| MIR107 microRNA 107 | 406901 HGNC:31496 | 0 | 0 | 0 | 0 | 1,194 | 3,765 |
| MIR15B microRNA 15b | 406949 HGNC:31544 | 0 | 0 | 0 | 0 | 1,354 | 3,765 |
| RBX1 ring-box 1 | 9978 HGNC:9928 | 1 | 61 | 6 | 1,695 | 2,387 | 3,762 |
| FLNB filamin B | 2317 HGNC:3755 | 1 | 38 | 0 | 0 | 2,659 | 3,759 |
| ISL1 ISL LIM homeobox 1 | 3670 HGNC:6132 | 1 | 63 | 0 | 0 | 3,140 | 3,753 |
| PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 5300 HGNC:8988 | 1 | 78 | 0 | 0 | 2,100 | 3,752 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=90
{
"data": {
"total": 193990,
"results": [
{
"id": "4287",
"title": "ATXN3: ataxin 3",
"summary": "NCBI Gene 4287. 1 protein, 42 patents, 0 drugs, 0 trials, 1,882 NIH grants and 3,790 papers.",
"record": "/library/genes/4287",
"gene_id": 4287,
"symbol": "ATXN3",
"name": "ataxin 3",
"hgnc_id": "HGNC:7106",
"counts": {
"proteins": 1,
"patents": 42,
"drugs": 0,
"trials": 0,
"grants": 1882,
"papers": 3790
}
},
{
"id": "7138",
"title": "TNNT1: troponin T1, slow skeletal type",
"summary": "NCBI Gene 7138. 1 protein, 15 patents, 0 drugs, 0 trials, 1,327 NIH grants and 3,788 papers.",
"record": "/library/genes/7138",
"gene_id": 7138,
"symbol": "TNNT1",
"name": "troponin T1, slow skeletal type",
"hgnc_id": "HGNC:11948",
"counts": {
"proteins": 1,
"patents": 15,
"drugs": 0,
"trials": 0,
"grants": 1327,
"papers": 3788
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=91",
"request_id": "KOl3oxltLmnDBJmM"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant